港股市场策略周报：流动性改善支持港股补涨，关注创新药与互联网机会-20250825

Market Outlook and Strategy - The improvement in liquidity narrative is expected to support a rebound in the Hong Kong stock market, narrowing the gap with the rapidly rising A-share market [1][3] - The current earnings forecast rate for Hong Kong stocks is at its highest since 2022, indicating a positive outlook for earnings improvement [1][6] - It is recommended to focus on sectors that differ from A-shares, with a suggested investment sequence of innovative drugs first, followed by the internet sector, and finally new consumption [1][7] Sector Recommendations - Recommended sectors include innovative drugs, internet, and non-bank financials, with specific indices provided for each [1][9] - The innovative drug sector is highlighted due to alleviated liquidity risks and high growth potential [9] - The internet sector is seen as having fully priced in earnings pressures, making it a potential area for growth in a loosening liquidity environment [9] - Non-bank financials are considered a good base choice in a bull market, with valuations significantly lower than A-shares, indicating potential for catch-up [9] Performance Review - The Hong Kong stock market saw a slight increase last week, with the Hang Seng Index rising by 0.27% and the Hang Seng Tech Index increasing by 1.89% [12][15] - The AH premium index expanded to 125.33, reflecting positive market sentiment [12] - The majority of sectors experienced gains, particularly non-essential consumption, information technology, and telecommunications, while materials, energy, and utilities lagged [15] Micro Liquidity Analysis - Average daily trading volume in the Hong Kong market reached 280.3 billion HKD, indicating a significant increase in trading activity [18] - There was a net inflow of 179 billion HKD from southbound funds, primarily directed towards financial, information technology, and healthcare sectors [29] - Local ETFs saw a net inflow of 5.5 billion HKD last week, contributing to a total net inflow of 45.1 billion HKD year-to-date [24][27] Earnings Disclosure - As of August 25, 2023, 699 Hong Kong-listed companies have issued earnings warnings, with 41% indicating positive earnings revisions, the highest rate in three years [6][8] - The technology, pharmaceutical, and new consumption sectors in Hong Kong have a higher representation compared to A-shares, suggesting potential for continued earnings improvement [6] Valuation Levels - The forward P/E ratio for the Hang Seng Index is currently at 11.6X, placing it in the 69.3 percentile since 2020, while the Hang Seng Tech Index stands at 19.3X, in the 24.6 percentile since its inception [33][35]